Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
In Silico Biosciences
Pharsight Simcyp XenologiQ |
| gptkbp:CEO |
William F. Feehery
|
| gptkbp:focusesOn |
clinical pharmacology
regulatory science model-informed drug development |
| gptkbp:foundedYear |
2008
|
| gptkbp:headquartersLocation |
gptkb:Princeton,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Certara
|
| gptkbp:industry |
pharmaceutical technology
biosimulation |
| gptkbp:numberOfEmployees |
over 1,200
|
| gptkbp:product |
BaseCase
D360 Phoenix WinNonlin Simcyp Simulator |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:CERT
|
| gptkbp:website |
https://www.certara.com/
|
| gptkbp:bfsParent |
gptkb:EQT_AB
|
| gptkbp:bfsLayer |
6
|